ABC | Volume 115, Nº2, Agosto 2020

Minieditorial Roque Qual Escore de Risco Melhor Avalia os Objetivos Clínicos para meu Paciente com Miocardiopatia Hipertrófica? Arq Bras Cardiol. 2020; 115(2):205-206 1. Braunwald E (2012).  “Hypertrophic cardiomyopathy: The first century 1869-1969”. Glob Cardiol Sci Pract. 2012 (1):5 2. Evans W.  “Familial cardiomegaly”. Br Heart J.1949; 11(1):68-82.  3. Pare JA, Fraser RG, Pirozynski WJ,Shanks JA, Stubington D.  “Hereditary cardiovascular dysplasia. A form of familial cardiomyopathy”. Am J Med. 31: 37–62.. 4. Teare D.  “Asymmetrical hypertrophy of the heart in young adults”. Br Heart J. 1958;20(1):1-8. 5. Brock R.  “Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis)”. Guys Hosp Rep.1959;108:126-43. 6. Maron BJ (2003).  “Sudden death in young athletes”.  N Engl J Med. 349(11):1064-75. 7. Shiozaki AA, Senra T, Arteaga E, Pita CG, Martinelli Filho M, Avila LF, et al. Myocardial fibrosis in patients with hypertrophic cardiomyopathy and high risk for sudden death. Arq Bras Cardiol.2010;94(4):535-40. 8. Gersh BJ, Maron BJ, BonowRO, Dearani JA, Fifer MA, LinkMS, et al. American College of Cardiology Foundation/American Heart Association task force on practiceguidelines;AmericanAssociationforThoracicSurgery;AmericanSociety of Echocardiography; American Society of Nuclear Cardiology; Heart Failure SocietyofAmerica;HeartRhythmSociety;SocietyforCardiovascularAngiography and Interventions; Society of Thoracic Surgeons. 2011 ACCF/AHA guideline for thediagnosisandtreatmentofhypertrophiccardiomyopathyexecutivesummary: a report of the American College of Cardiology Foundation/American Heart Associationtaskforceonpracticeguidelines.Circulation.2011;124(24):2761-96. 9. O’Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, et al. Hypertrophic cardiomyopathy outcomes investigators. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCMrisk-SCD).EurHeartJ.2014;35(30):2010-20. 10. Moonsk,AltmanDG,VergouweY,RoystonP.Prognosisandprognosticresearch: application and impact of prognostic models in clinical practice. BMJ. 2009 Jun 04;338:b606doi:10.1136/bmj.b606 11. MattosBP,ScolariFL,GarbinHI .Discrepancybetween InternationalGuidelines ontheCriteriaforPrimaryPreventionofSuddenCardiacDeath inHypertrophic Cardiomyopathy.ArqBrasCardiol.2020;115(2):197-204). Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 206